Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $172.82 USD
Change Today +2.05 / 1.20%
Volume 258.6K
JAZZ On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kathryn E. Falberg

AgeTotal Calculated CompensationThis person is connected to 62 board members in 5 different organizations across 14 different industries.

See Board Relationships
54$285,003
As of Fiscal Year 2014

Background*

Ms. Kathryn E. Falberg, also known as Kate, served as the Chief Financial Officer of Jazz Pharmaceuticals Public Limited Company from 2009 to March 9, 2014 and its Executive Vice President from March 2012 to February 2014 and Senior Vice President from December 2009 to 2012. Ms. Falberg serves as the Chief Financial Officer and Senior Vice President of Azur Pharma Public Limited Company. She served as the Chief Operating Officer and Chief Financial Officer at ARCA biopharma, ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: 353 1 634 7850

Board Members Memberships*

Director
2007-Present
Chairman of the Board, Chairman of Audit Committee and Member of Compensation Committee
2013-Present
Director and Chairman of Audit Committee
2014-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2015-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

BA
University of California-Los Angeles
MBA
University of California-Los Angeles

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$85,000
Total Calculated Compensation$285,003
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $172.82 USD +2.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.